Navigation Links
Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
Date:3/1/2011

statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-Q for the quarter ended September 30, 2010.  All forward-looking statements are qualified in their entirety by this cautionary statement.  Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015  Cardica, Inc. (Nasdaq: CRDC ) today announced ... quarter ended June 30, 2015, on Thursday, August 6, 2015, ... call at 4:30 p.m. Eastern Time to discuss the financial ... Conference Call Details To access the live conference ... via phone, please dial 877-703-6106 from the United ...
(Date:7/27/2015)... 27, 2015 Syneron Medical Ltd. ... global market leader in the aesthetic medical device marketplace, ... Food and Drug Safety (MFDS) regulatory clearance for the ... can fulfill PicoWay orders from its Korean distribution partner, ... in the third quarter 2015. Amit Meridor, ...
(Date:7/27/2015)... 27, 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), ... treatment of chronic pain, today announced that it ... Heath Canada to conduct a multiple ... REL-1017), its novel, N-methyl-D-aspartate (NMDA) receptor antagonist being ... "We are very encouraged by the initial ...
Breaking Medicine Technology:Cardica To Announce Fiscal 2015 Fourth Quarter Financial Results On Thursday, August 6, 2015 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... September 30, 2011 and provided a business update.  The ... and 2010, as reported in accordance with accounting principles ... million and $0.6 million, respectively.  The net losses for ...
... 7, 2011 Planet Biopharmaceuticals, Inc. and its wholly ... company focused on providing products for allergy and asthma ... sale of ALLERGY CONTROL PRODUCTS, INC., a Delaware corporation("ACP") ... liability company. Theron E. Odlaug, Ph. D., ...
Cached Medicine Technology:Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 Third Quarter Financial Results and Provides Business Update 7
(Date:7/28/2015)... ... July 28, 2015 , ... North American Seminars will ... fall of 2015 . These seventeen courses are pre-approved for CME credit ... Functional Mobility in the Older Adult , August 22, 2015 - August ...
(Date:7/28/2015)... ... ... the Veterans Fund of the United States, managing the United Veteran Beacon House (UVBH) for ... to help homeless Veterans by giving them “A hand up – not a hand out.” ... assists and supports Vets through the Veterans Fund of the United States (VFUS), ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s New ... http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is hard ... can get messy in a hurry. In a 46-page draft guidance released in January, ...
(Date:7/27/2015)... , ... July 28, 2015 , ... The National ... inductee into the NAPW VIP Woman of the Year Circle. She is recognized with ... 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... wound center management. Earlier this year Wound Care Advantage beta launched ... for WCA wound centers. Customized learning paths allow for clinicians, physicians, hyperbaric ...
Breaking Medicine News(10 mins):Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 2Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 3Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 4Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 5Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 6Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 7Health News:North American Seminars receives California PT Board approval for Seventeen Continuing Education Courses presented in the Fall of 2015. 8Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3
... distributed to Kids attending the event with their parents. Food, Entertainment ... ,Florida KidCare - Back to School - Enrollment Fair Sunday, August 3, ... - Shoppes of Cresthaven - (Military Trail & Cresthaven Blvd) West Palm ... ...
... 1 Mark Merritt, President,of the Pharmaceutical ... response to new comparative effectiveness legislation,introduced late ... Max Baucus,(D-Mont.) and Senate Budget Committee Chair ... Baucus and Conrad for helping advance the,discussion ...
... 1 Community-based oral health,programs in Michigan, Ohio, ... to $5,000 from the Delta Dental Foundation,s third ... by Nancy E. Hostetler,senior vice president of the ... of $70,000 will be awarded in competitive grants,this ...
... it,s unclear whether treating the breathing disorder cuts the ... News) -- The interrupted nighttime breathing of sleep apnea ... report. , Earlier studies have linked sleep apnea to ... in sleep centers rather than in the general community. ...
... 2008) -- Quality of care varies greatly for the treatment ... country and category of health care facility, suggesting the potential ... to a new study that was published in the Aug. ... (2008: Vol. 26, Issue 22). , The inconsistencies in care ...
... of Medicine have discovered that a protein called FOXA2 controls ... liver. FOXA2 may become the focus for new therapies to ... study was published online this week in Nature Medicine ... in the gall bladder and transported through ducts to the ...
Cached Medicine News:Health News:Florida KidCare News Conference and Back to School Enrollment Fair 2Health News:Delta Dental Foundation Calls for Applicants for Annual Community Mini-Grant Program 2Health News:Sleep Apnea Boosts Death Risk 2Health News:Sleep Apnea Boosts Death Risk 3Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2
... provide you with everything you need ... evoked potential, or electro-oculogram. The ultra-bright ... to perform ERGs you never imagined ... negative response, and s-cone ERGs. Wireless ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... designed for high throughput microplate processing. The ... Stacker that handles up to 60 microplates ... model is equipped with a dual direct ... may be interfaced to increase flexibility as ...
... Processor is a precise, reliable and ... has been designed for OEM production. ... customised according to the method bottles ... able to process automatically the whole ...
Medicine Products: